Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

NCT04504370 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

273

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: GLP-1 receptor agonist
DRUG: Placebo

Sponsor

PegBio Co., Ltd.